SURVIVING FRACTION AT 2 Gy VERSUS CONTROL OF HUMAN CERVICAL CARCINOMA - UPDATE OF THE MANCHESTER STUDY
- 1 January 1992
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneityRadiotherapy and Oncology, 1990
- The ESTRO Regaud lecture Inherent radio sensitivity of tumor and normal tissue cells as a predictor of human tumor responseRadiotherapy and Oncology, 1990
- The effect, of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: A theoretical evaluationInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Evaluation of Surviving Fraction at 2 Gy as a Potential Prognostic Factor for the Radiotherapy of Carcinoma of the CervixInternational Journal of Radiation Biology, 1989
- A clinical trial of two conceptually different radical radiotherapy treatments in Stage III carcinoma of the cervixClinical Radiology, 1986
- Stage III carcinoma of cervix. The importance of increasing age and extent of parametrial infiltrationRadiotherapy and Oncology, 1986